Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2018 pubmed 33 citations

Centrally administered kisspeptin suppresses feeding via nesfatin-1 and oxytocin in male rats.

Saito. Reiko R; Tanaka. Kentaro K; Nishimura. Haruki H; Nishimura. Kazuaki K; Sonoda. Satomi S; Ueno. Hiromichi H; Motojima. Yasuhito Y; Yoshimura. Mitsuhiro M; Maruyama. Takashi T; Yamamoto. Yukiyo Y; Kusuhara. Koichi K; Ueta. Yoichi Y

Key Findings

  • Central (intracerebroventricular) injection of kisspeptin‑10 sharply cuts food intake in male rats for up to 3 hours.
  • Kisspeptin‑10 activates nesfatin‑1‑producing neurons in several hypothalamic and brainstem regions.
  • Kisspeptin‑10 also activates oxytocin‑producing neurons; blocking oxytocin receptors partially reverses the reduced eating.
  • Interfering with nesfatin‑1 production (using antisense RNA) also weakens kisspeptin‑induced anorexia.

Practical Outcomes

  • For DIY health enthusiasts, the study suggests kisspeptin can influence appetite via brain pathways, but the method used (direct brain injection) isn’t feasible in humans. It points to the idea that kisspeptin‑based compounds might one day be explored as appetite‑suppressing agents, though safe, oral or peripheral delivery methods would be needed first.

Summary

Giving rats a dose of kisspeptin-10 directly into the brain made them eat less for a few hours. The effect seems to happen because kisspeptin turns on two other brain chemicals, nesfatin‑1 and oxytocin, that are known to reduce hunger. Blocking these downstream signals lessened the appetite‑suppressing effect.

Abstract

Kisspeptin (KP), known as a hypothalamic neuropeptide, plays a critical role in the regulation of not only reproduction but also food intake. The anorectic neuropeptides, nesfatin-1 and oxytocin (OXT), are expressed in central nervous system, particulaly in various hypothalamic nuclei, and peripheral tissue. We examined the effects of the intracerebroventricular (icv) administration of KP-10 on feeding and nesfatin-1-immunoreactive (ir) or OXT-ir neurons in the rat hypothalamus, using Fos double immunohistochemistry in male rats. Cumulative food intake was remarkably decreased 0.5-3 h after icv administration of KP-10 (6.0 μg) compared to the vehicle treated and the KP-10 (3.8 μg) treated group. The icv administration of KP-10 significantly increased the number of nesfatin-1-ir neurons expressing Fos in the supraoptic nucleus (SON), paraventricular nucleus (PVN), arcuate nucleus (ARC), dorsal raphe nucleus, locus coeruleus, and nucleus tractus solitarius. The decreased food intake induced by KP-10 was significantly attenuated by pretreatment with the icv administration of antisense RNA against nucleobindin-2. After icv administration of KP-10, the percentages of OXT-ir neurons expressing FOS were remarkably higher in the SON and PVN than for vehicle treatment. The KP-10-induced anorexia was partially abolished by pretreatment with OXT receptor antagonist (OXTR-A). The percentage of nesfatin-1-ir neurons expressing Fos-ir in the ARC was also decreased by OXTR-A pretreatment. These results indicate that central administration of KP-10 activates nesfatin-1- and OXT neurons, and may play an important role in the suppression of feeding in male rats.

Study Information

Provider

pubmed

Year

2018

Date

2018-12-16T00:00:00.000Z

DOI

10.1016/j.peptides.2018.12.003

Citations

33

References

48